Bayes factors for superiority, non-inferiority, and equivalence designs
Abstract Background In clinical trials, study designs may focus on assessment of superiority, equivalence, or non-inferiority, of a new medicine or treatment as compared to a control. Typically, evidence in each of these paradigms is quantified with a variant of the null hypothesis significance test...
Main Authors: | Don van Ravenzwaaij, Rei Monden, Jorge N. Tendeiro, John P. A. Ioannidis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12874-019-0699-7 |
Similar Items
-
baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs
by: Maximilian Linde, et al.
Published: (2023-11-01) -
Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop
by: Nikki Totton, et al.
Published: (2023-10-01) -
A Bayesian non-inferiority approach using experts’ margin elicitation – application to the monitoring of safety events
by: Camille Aupiais, et al.
Published: (2019-09-01) -
Non-inferiority versus superiority drug claims: the (not so) subtle distinction
by: Jitendra Ganju, et al.
Published: (2017-06-01) -
Segmental Bayesian estimation of gap-junctional and inhibitory conductance of inferior olive neurons from spike trains with complicated dynamics
by: Huu eHoang, et al.
Published: (2015-05-01)